Replek AD Skopje operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Replek AD Skopje with three other
pharmaceutical manufacturers in Europe:
sales of 16.84 million Euro [US$19.46 million]
Science In Sport Plc
of the United Kingdom
(£15.62 million [US$20.55 million]
of which 89%
was Core), and
based in Norway
(150.91 million Norwegian Kroner [US$18.47 million]
of which 57%
was Hexvix/Cysview Own Sales).